Biography

Professor Stevens began his college education in 1964 graduating from the Pennsylvania State University with a B.S. (1967) in Science. He worked a year at Norwich Pharmacal Company in Norwich, New York before continuing his graduate education at West Virginia University in Morgantown, West Virginia. He completed a M.S. (1970) in Reproductive Physiology and Ph.D. (1972) in Pharmacology.

Dr. Stevens worked as an assistant professor at Hershey Medicine School in Hershey, Pennsylvania from 1972 to 1975 until taking a job as Section Chief in Inhalation Toxicology at the US Environmental Protection Agency in Research Triangle Park, NC. Dr. Stevens began a long career with industry in 1977, working for the same company under different names (CIBA-GEIGY, CIBA, Novartis, and Syngenta), until he retired as the Head of Global Human Risk Assessment at the end of 2002. Stevens had donated time to Wake Forest University School of Medicine for nearly two decades and 2000 brought nearly $200,000 grant funds. Stevens attained the rank of professor and faculty in 2003.

Professor Stevens has over thirty years of experience in academia, government and industry. He has a foundation in principles of experimental design, reproductive physiology, biochemical pharmacology, general toxicology, inhalation toxicology, regulatory toxicology, toxicology management, food safety, contract management, general management, facility management, and teaching. Despite a primarily industrial background, Stevens has more than 75 published chapters or papers (55 abstracts); he is a 30-year member of the Society of Toxicology and the American Society of Pharmacology and Experimental Therapeutics, and has quadruple certification in Toxicology being Diplomat of the American Board of Toxicology, Fellow of the Academy of Toxicological Sciences, Certification, Swiss Professional Register of Toxicology and Eurotox Registered Toxicologist. He has led and served on several national and international government and industrial committees including, currently, the US Environmental Protection Agency's FACA, the Endocrine Disruptors Method Validation Advisory Committee.